Source: Contract Pharma

Pii: Pii Introduces Accelevate Early Development Platform

Accelerates the preparation of IND submissions, allowing pharmaceutical companies to reach IND readiness in 100 days for aseptic products.

Read full article »

Pii's Competitors | Pii's News | Pii's Financials

Followers on Owler

237

Est. Annual Revenue

$100-500M

Est. Employees

250-500

President & CEO

John Fowler

CEO Approval Rating

90/100

Pii is a Maryland-based CRO that provides services including product formulation, contract analysis and drug development for the pharmaceutical industry.